Background
Distal embolization is a serious complication in patients (pts) with acute myocardial infarction (MI) undergoing PCI. The Mguard stent (MGS) is a novel mesh-covered stent designed to prevent thrombus embolization. The combined use of thrombus aspiration + MGS has not been evaluated yet. This study was designed to address this question.
Methods
This was a single-center, single-arm, prospective registry that included all pts treated with the MGS from July 2010 to July 2011. Criteria for MGS implantation were acute MI and evidence of high thrombus burden despite mechanical aspiration. Lesions with a side branch ≥ 2 mm and pts with cardiogenic shock were not included. The study endpoints were proportion of final TIMI 3 flow, normal myocardial blush, and complete ST-segment resolution.
Methods
This was a single-center, single-arm, prospective registry that included all pts treated with the MGS from July 2010 to July 2011. Criteria for MGS implantation were acute MI and evidence of high thrombus burden despite mechanical aspiration. Lesions with a side branch ≥ 2 mm and pts with cardiogenic shock were not included. The study endpoints were proportion of final TIMI 3 flow, normal myocardial blush, and complete ST-segment resolution.